Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 448 results for "ranbaxy lab"

'Sun Pharma-Ranbaxy Lab deal a smart move'
Money Today

Sun Pharma, Ranbaxy gain on brokerages' upgrade

Sun Pharma has rallied 5% to Rs 618, while Ranbaxy Lab up 3% at Rs 459 on the National Stock Exchange. SI Reporter | Mumbai April 9, 2014 Last Updated at 10:05 IST Shares in Sun Pharmaceuticals Industries and Ranbaxy Laboratories are trading higher by up to ... Business Standard, 1 week ago
Sebi probing stock bounce before deal The Financial Chronicle, 1 week ago
Sky is the Limit for Indian Drug Firms New Indian Express, 1 week ago
[x]  

38 images for ranbaxy lab

Sify, 5 days ago
International Reporter, 1 week ago
Business Today India, 1 week ago
Rediff.com, 1 week ago
1440 WNFL, 1 week ago
Financial Express, 1 month ago
Sify, 1 month ago
American Banking News, 1 month ago
Money Today, 1 week ago
Times of India, 1 week ago

Bullish on Dr Reddy's Lab, Lupin; sell Ranbaxy: Gaurang Shah

o Pharman too looks good. So, I would use opportunities on higher levels to lighten up position on Ranbaxy, says Shah. In a chat with ET Now, Gaurang Shah, VP, Geojit BNP Paribas Financial Services, shares his recommendations on Pharma stocks. Excerpt: ET ...
 Economic Times2 months ago Sun Pharma, Lupin, Ranbaxy to get astro support: Gupta  Money Control1 week ago Sun Pharma, Cipla, ACC, HCC to get astro support: Gupta  Money Control1 week ago
International Reporter

Ranbaxy Lab shares down 5% on Sun Pharma deal

Laboratories today tanked by 5 per cent after a deal by Sun Pharmaceutical Industries to fully acquire the troubled company in an all-stock transaction with a total equity value of USD 3.2 billion. Despite making a positive opening, shares of Ranbaxy went ...
 Business Standard1 week ago Regulatory lens on RanbaxySun deal share zoom  Hindustan Times1 week ago Ranbaxy Lab shares down 5 percent on Sun Pharma deal  Jagran Post1 week ago Ranbaxy Labs shares down 5% on Sun Pharma deal  Business Line1 week ago
[x]  
Financial Express

Dr Reddy's Lab, Ranbaxy, Glenmark shares hit by worries about Russia, Ukraine sales

Shares in Indian drugmakers fall, with Dr Reddys Laboratories down 1.9 per cent, on concerns that sales in Russia and Ukraine will be hit given military tensions between the two countries. Dr. Reddy's has the highest exposure to Russia and former ...
 Financial Express1 month ago Impact on Indian pharma cos from Russia-Ukraine crisis  Money Control1 month ago

Ranbaxy Lab settles with the New York Attorney General - Angel Broking

The New York Attorney General and the U.S. units of Ranbaxy Laboratories and Teva Pharmaceutical Industries have settled claims that an agreement between the two drugmakers unlawfully restricted competition. Under the terms of the settlement, the ...
 Equity Bulls1 month ago Ranbaxy Lab gains on buzz of settlement with Teva  India Infoline1 month ago Ranbaxy Lab gains on jointly settling New York Antitrust Claims with Teva  Arihant Capital1 month ago Ranbaxy, Teva settle claims with New York AG  Economic Times1 month ago
Financial Express

Ranbaxy Laboratories gets Supreme Court notice over adulterated drugs being sold in India

Supreme Court issues notice to Centre, Ranbaxy Lab on a PIL seeking cancellation of
 Financial Express1 month ago

Ranbaxy Lab gains as Q4 net loss narrows

after the company reported a consolidated net loss of Rs 158.94 crore for Q4 December 2013, lower than net loss of Rs 492.44 crore in Q4 December 2012. The Q4 result was announced during trading hours today, 5 February 2014. Meanwhile, the S&P BSE Sensex was ...
 Business Standard2 months ago Ranbaxy Lab extends intraday gains as net loss narrows in Q4  Business Standard2 months ago

Ranbaxy Lab recovers on bargain hunting

with the stock recovering on bargain hunting after recent steep slide triggered by the US drug regulator banning the company's Toansa facility in India from importing drugs to the US. Meanwhile, the S&P BSE Sensex was down 50.52 points or 0.24% at 20,656.93.
 Business Standard2 months ago

Ranbaxy Lab slumps over 17%

A bout of volatility was witnessed as key benchmark indices trimmed losses after a lower start triggered by weak Asian stocks. The barometer index, the S&P BSESensex, was down 51.35 points or 0.28%, up about 95 points from the day's low and off close to 5 ...
 Business Standard2 months ago

PTI - STOC-MUM-CLOSE 7 - RANBAXY LAB.

STOC-MUM-CLOSE 7 - RANBAXY LAB. Contributed by NAMPA / PTI. 365.05 RECLTD 228.80 REL COM LTD 128.85 REL INFRA 435.05 REL.CAP. 346.00 RELIANCE 929.50 RPOWER 70.35 SHREE CEMENT 5638.40 SHRIRAM TRAN 763.15 SHRMCITYUN 1101.45 SIEMENS LTD. ...
 Namibia Press Agency2 weeks ago PTI - STOCK MUM CLOSE 6 - NATIONAL FER  Namibia Press Agency4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy lab
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less